Channing Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.35M | Buy |
50,345
+2,270
| +5% | +$421K | 0.26% | 72 |
|
|
2025
Q1 | $10.1M | Sell |
48,075
-12,723
| -21% | -$2.67M | 0.3% | 60 |
|
|
2024
Q4 | $10.8M | Buy |
60,798
+5,397
| +10% | +$959K | 0.29% | 59 |
|
|
2024
Q3 | $10.9M | Sell |
55,401
-2,911
| -5% | -$575K | 0.28% | 58 |
|
|
2024
Q2 | $10M | Buy |
58,312
+5,826
| +11% | +$999K | 0.27% | 63 |
|
|
2024
Q1 | $9.56M | Sell |
52,486
-6,500
| -11% | -$1.18M | 0.26% | 69 |
|
|
2023
Q4 | $9.14M | Buy |
58,986
+3,152
| +6% | +$488K | 0.27% | 63 |
|
|
2023
Q3 | $8.32M | Sell |
55,834
-6,831
| -11% | -$1.02M | 0.27% | 62 |
|
|
2023
Q2 | $8.44M | Buy |
62,665
+9,218
| +17% | +$1.24M | 0.26% | 65 |
|
|
2023
Q1 | $8.52M | Sell |
53,447
-15,984
| -23% | -$2.55M | 0.27% | 73 |
|
|
2022
Q4 | $11.2M | Buy |
+69,431
| New | +$11.2M | 0.36% | 69 |
|
|
2019
Q1 | – | Sell |
-62,619
| Closed | -$5.77M | – | 107 |
|
|
2018
Q4 | $5.77M | Sell |
62,619
-26,719
| -30% | -$2.46M | 0.29% | 82 |
|
|
2018
Q3 | $8.45M | Buy |
89,338
+25,686
| +40% | +$2.43M | 0.3% | 72 |
|
|
2018
Q2 | $5.9M | Buy |
+63,652
| New | +$5.9M | 0.21% | 87 |
|
|
2014
Q1 | – | Sell |
-32,615
| Closed | -$1.72M | – | 97 |
|
|
2013
Q4 | $1.72M | Hold |
32,615
| – | – | 0.11% | 96 |
|
|
2013
Q3 | $1.46M | Hold |
32,615
| – | – | 0.11% | 98 |
|
|
2013
Q2 | $1.35M | Buy |
+32,615
| New | +$1.35M | 0.12% | 97 |
|